Aclaris Therapeutics

Aclaris Therapeutics is a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions. It focuses on leveraging core expertise in drug discovery and development and kinase inhibition to develop novel small and large molecule drugs for underserved immuno-inflammatory conditions. The company also operates Confluence Discovery Technologies, Inc., a full-service drug discovery and early development contract research organization.

Aclaris Therapeutics is a biopharmaceutical company focused on immuno-inflammatory conditions. It uses the proprietary KINect technology platform for kinome innovation and develops kinase inhibitors and biologic product candidates. It operates Confluence Discovery Technologies, Inc., a contract research organization.

1. Home | Aclaris Therapeutics Inc.
2. Overview | Aclaris Therapeutics Inc.
3. Corporate Compliance | Aclaris Therapeutics Inc.
4. Aclaris Therapeutics (United States)